Massive Bio is a healthcare technology company that connects cancer patients and their treating oncologists to clinical trials and advanced care plans. The company's platform uses artificial intelligence and machine learning to match patients with the most appropriate clinical trials and treatments based on their unique medical history and genomic profile. Massive Bio's mission is to improve patient outcomes and accelerate the development of new cancer treatments through the use of technology and data-driven insights.